Cover of: Cardiac Safety of Noncardiac Drugs |

Cardiac Safety of Noncardiac Drugs

Practical Guidelines for Clinical Research and Drug Development
  • 372 Pages
  • 1.71 MB
  • 2431 Downloads
  • English

Humana Press
Cardiovascular medicine, Pharmacology, Medical, Drugs, Medical / Nursing, Testing, Side effects, Cardiology, Medical / Pharmacology, Cardiovascular toxicology, Effect of drugs on,
ContributionsJoel Morganroth (Editor), Ihor Gussak (Editor)
The Physical Object
FormatHardcover
ID Numbers
Open LibraryOL8828546M
ISBN 10158829515X
ISBN 139781588295156

In Cardiac Safety of Noncardiac Drugs: Practical Guidelines for Clinical Research and Drug Development, basic and clinical researchers from industry and academia detail the preclinical, clinical, and regulatory principles currently used to assess the cardiac safety of new drugs from their effects on the electrocardiogram (ECG).

Cardiac Safety of Noncardiac Drugs: Practical Guide- Joel Morganroth, MD lines for Clinical Research and Drug Development is designed to present the current preclinical, clinical, and re- latory principles to assess the cardiac safety of new drugs based primarily on their effects on the cturer: Humana.

Cardiac Safety of Noncardiac Drugs: Practical Guide- Joel Morganroth, MD lines for Clinical Research and Drug Development is designed to present the current preclinical, clinical, and re- latory principles to assess the cardiac safety of new drugs based primarily on their effects on the ECG.

Practical gu- ance to define cardiac safety at all Format: Hardcover. We use cookies to offer you a better experience, personalize content, tailor advertising, provide social media features, and better understand the use of our services.

Integrated Cardiac Safety provides necessary guidance and methodology for professionals assessing cardiac safety of drugs throughout all stages of the drug's life, from discovery and development through postmarketing research. This self-contained, reader-friendly text is valuable to professionals in the pharmaceutical, biotechnology, and CRO.

Cardiac safety of noncardiac drugs Edited by Morganroth, and Gussack, ISBN 1‐‐‐6 Published by Humana Press Few issues have resulted in more regulatory action than the problem of abnormal cardiac repolarization, QT interval prolongation, torsade Author: S.

Thomas. Download Citation | Cardiac safety of noncardiac drugs: Practical guidelines for clinical research and drug development | Although it is relatively easy to determine the efficacy of a new drug, it.

The editors of Cardiac Safety of Noncardiac Drugs wish to recognize the significant contribution made by all of the contributing authors. The book is the result of a collabo-ration that has brought together the skills and perspectives of researchers, scientists, and clinicians.

Finally, we hope that the book will become a primary reference for drug. Book review Cardiac safety of noncardiac drugs Edited by Morganroth and Gussack, ISBN Published by Humana Press Few issues have resulted in more regulatory action than the problem of abnormal cardiac repolarization, QT interval prolongation, torsade de pointes and sudden cardiac death induced by drug therapy.

Although a riskAuthor: S. Thomas. Rather, this focus is upon drugs that have not been developed for the express purpose of modifying the behavior of cardiac ion channels, but as we all know many unexpectedly do.

Keywords Cardiac Repolarization Cardiac Safety Nonsedating Antihistamine Fixed Exponent Digital ECGSCited by: 1.

Details Cardiac Safety of Noncardiac Drugs FB2

Cardiac safety of noncardiac drugs Cardiac safety of noncardiac drugs Thomas, S. Cardiac safety of noncardiac drugs Edited by Morganroth and Gussack, ISBN 1‐‐‐6 Published by Humana Press Few issues have resulted in more regulatory action than the problem of abnormal cardiac repolarization, QT interval prolongation, torsade de pointes and.

"Authoritative and up-to-date, Cardiac Safety of Noncardiac Drugs: Practical Guidelines for Clinical Research and Drug Development offers clinical researchers in industry and academia expert practical advice on establishing their product's cardiac safety, predicting regulatory actions, and getting it successfully to market."--Jacket.

Free Online Library: Integrated cardiac safety; assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance.(Brief article, Book review) by "SciTech Book News"; Publishing industry Library and information science Science and.

Book at Library Mkii Integrated Cardiac Safety: Assessment Methodologies for Noncardiac Drugs in Discovery, Development, and Postmarketing Surveillance - Book at Library Mkii Search this site.

Book review Book review Osbakken, Mary Cardiac Safety of Noncardiac Drugs: Practical Guidelines for Clinical Research and Drug Development edited by Joel Morganroth and Ihor Gussak is an interesting collection of commentaries on the cardiac safety of noncardiac drugs.

The chapter book is divided into 5 sections, including a brief introduction by Ray. ISBN: X OCLC Number: Description: xii, pages: illustrations ; 27 cm: Contents: Ch. Cardiac safety of noncardiac drugs: historical recollections --ch.

lar physiology of ion channels that control cardiac repolarization / Jeanne M. Nerbonne and Robert S. Kass --ch. ar, molecular, and pharmacologic mechanisms underlying drug-induced.

Description Cardiac Safety of Noncardiac Drugs PDF

The title of this book could potentially mislead. It is not a general account of the cardiac safety of drugs but deals only with this type of pro-arrhythmia. Those looking for advice on other drug-induced cardiac problems, for example, myocardial infarction, will be disappointed.

Nevertheless, what is included is covered very well. Assessment Methodologies for Noncardiac Drugs in Discovery, Development, and Postmarketing Surveillance by J. Rick Turner. Integrated Cardiac Safety provides necessary guidance and methodology for professionals assessing cardiac safety of drugs throughout all stages of the drug's life, from discovery and development through postmarketing research.

Integrated Cardiac Safety by J. Rick Turner,available at Book Depository with free delivery worldwide. The guidelines for the perioperative evaluation and management of patients undergoing noncardiac surgery focus on patients undergoing noncardiac surgery who are at risk of perioperative cardiac morbidity or mortality.

This at-risk group includes patients with known CAD, patients with recent signs or symptoms suggestive of CAD, and asymptomatic patients older than 50 years who have the. Non-steroidal anti-inflammatory drugs are widely used for dental pain and dentists should be aware of the potential cardiac adverse effects, particularly with long-term use of these drugs.

The concept of using these very effective drugs for the shortest time possible at the lowest effective dose is an excellent guiding principle for all by: 1.

Chairman, Department of Clinical Research, Campbell University School of Pharmacy and Member of the Cardiac Safety Research Consortium. Search for more papers by this author. Todd A. Durham MS. Book Author(s). Guidance from today’s leaders in cardiac anesthesia, helping you avoid complications and ensure maximum patient safety.

More than full-color illustrations. A new section on anesthetic management of the cardiac patient undergoing noncardiac surgery. Aims To assess the association between the use of non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death.

Download Cardiac Safety of Noncardiac Drugs FB2

Methods and results A population-based case–control study was performed in the Integrated Primary Care Information (IPCI) project, a longitudinal observational database with complete medical records from more than by:   The book is divided into six sections, beginning with a section on general considerations; this includes an introduction and history of cardiac anaesthesia, guidance on the preoperative evaluation of patients with cardiovascular disease, and a chapter on cardiovascular drugs.

Each chapter in the cardiac anaesthesia section covers a specific. Integrated cardiac safety, this book's central tenet, sets forth an effective strategy that enables researchers in drug discovery and development to better assess the cardiac safety of drugs.

It entails the use and integration of the methodologies used to assess cardiac safety during the full life cycle of drug development from discovery and. kaplan s cardiac anesthesia Download kaplan s cardiac anesthesia or read online books in PDF, EPUB, Tuebl, and Mobi Format.

Click Download or Read Online button to get kaplan s cardiac anesthesia book now. This site is like a library, Use search box in the widget to get ebook that you want. Complete coverage of echocardiography and current monitoring techniques. Guidance from today’s leaders in cardiac anesthesia, helping you avoid complications and ensure maximum patient safety.

More than full-color illustrations. A new section on anesthetic management of the cardiac patient undergoing noncardiac surgery. The cardioprotective effects of volatile anesthetics versus total intravenous anesthesia (TIVA) are controversial, especially in patients undergoing non-cardiac surgery.

Using current generation high-sensitivity cardiac troponin (hs-cTn), we aimed to evaluate the effect of anesthetics on the occurrence of myocardial injury after non-cardiac surgery (MINS). From February to December Cited by: 1. Clinical Rhythmology: Diagnosis and Treatment of Electrical Diseases of the Heart, and Prevention of Sudden Cardiac Death.

pp ; Cardiac Safety of NonCardiac Drugs: Practical Guidelines for Clinical Research and Drug Development. Edited by J. Morganroth and I.

Gussak. Humana, ; Cardiac Repolarization: Bridging Basic and Clinical. His work focuses on assessing the cardiac safety of non-cardiac drugs. He has spoken before two FDA Advisory Committees on cardiovascular safety issues, given numerous presentations at international conferences, and published several recent peer-reviewed papers in this : Springer-Verlag New York.Cardiac safety of noncardiac drugs: practical guidelines for clinical research and drug development / edited by Joel Morganroth, Ihor Gussak.

p. cm. Includes bibliographical references and index. ISBN X (alk. paper) 1. Cardiovascular toxicology. 2. Heart--Effect of drugs on.

3. Drugs--Side effects--Testing. 4. Electrocardiography. I.Also covers new information on targeted gene therapy, pharmacology of anaesthetic and cardiac drugs, transesophageal echocardiography, minimally invasive/robotic cardiac surgery, cardiac assist devices and artificial hearts, and many more cutting-edge topics.

Category: Medical Essentials Of Cardiac Anesthesia For Noncardiac Surgery E Book.